We are pleased to announce our Keynote speakers.

  • Infrastructure for world-Wide Clinical Trials Conduct and Analysis: The BeiGene Case Study
    by Alan Hopkins, BeiGene

    Mr. Hopkins is the Vice President of Global Biometrics at BioGene, a pharmaceutical company founded in China. His speech is about building a wholly new international biometrics organization with best-in-class tools available to support the clinical data and analysis world-wide.

  • China regulations in clinical trial
    by Dr. Qin Huang, CFDA

    Dr. Qin Huang, Doctor of Medicine, former senior clinical reviewer and chief review reporter of the National Center for Drug Evaluation (CDE), former deputy director of the statistics division (presiding work) and reviewer of vaccine clinical trial in CDE. He is currently a deputy chairman of several professional societies and professor at the university. Dr. Huang engaged in drug clinical review and statistical review for 16 years, focusing on the indications of cancer, digestion, psychology, vaccines and antibiotics. He presided over the formulation of several important regulatory documents of the State Food and Drug Administration (CFDA). Before he worked in CDE, he worked in the clinical research in the AIDS Center of the Ministry of Health and the Second Affiliated Hospital of Harbin Medical University.

  • Electronic data submission in Japan – PMDA experiences of receiving and using study data
    by Yuki Ando, PMDA

  • Sneak peek into CDSCO, India – Foot view and beyond the horizon
    by a representative (TBD), CDSCO (Central Drugs Standard Control Organization)